Open Access | Aug 2026 Real-world pharmacokinetics of albutrepenonacog alfa (rFIX-FP) in haemophilia B: comparison of population-based and one-compartment models Olga Benítez Hidalgo Juan Carlos Juárez Giménez Cristina Sierra Aisa José Antonio Romero Garrido Sara González Pineiro José Bruno Montoro Ronsano
Open Access | Jul 2026 Real-world Treatment Patterns and Outcomes of Switching to Efanesoctocog Alfa in Children with Haemophilia A: A Single-Centre Experience from the United Arab Emirates Muhammad Faisal Khanani Najam Awan Haydar Jawad Alrufaey Manal Rayyan Layla Al Reheymi
Open Access | Oct 2026 Use of eptacog beta for perioperative haemostatic management in major surgery in people with haemophilia A and inhibitors receiving emicizumab prophylaxis: A US case series Miguel A Escobar Sonia Nasr David Doherty John C Quinn Tyler W Buckner Madeleine Ochs Lauren Shevell Kylee L Martens Doris Quon Steven W Pipe
Open Access | Oct 2026 The Paradox of 'Non-Severe' Haemophilia: Qualitative Analysis of Treatment Disparities and Quality of Life Impacts from the Learning to Live Study Simon Fletcher Kathryn Jenner Kate Khair
Open Access | Sep 2026 Identifying Mental Health Needs in Extremely Rare Inherited Bleeding Disorders (ERBD): A Narrative Review Amy Owen-Wyard Stacey Mcgeown Emma Hallard Helen Tate